Vernalis plc’s (VER) “Hold” Rating Reaffirmed at N+1 Singer
N+1 Singer reaffirmed their hold rating on shares of Vernalis plc (LON:VER) in a research note issued to investors on Thursday morning. N+1 Singer currently has a GBX 46 ($0.60) price objective on the stock.
Other research analysts also recently issued research reports about the stock. Canaccord Genuity reissued a buy rating and set a GBX 84 ($1.10) price objective on shares of Vernalis plc in a report on Tuesday, September 6th. Shore Capital reissued a house stock rating on shares of Vernalis plc in a report on Tuesday, July 19th. Stifel Nicolaus increased their price objective on shares of Vernalis plc from GBX 94 ($1.23) to GBX 99 ($1.29) and gave the company a buy rating in a report on Tuesday, September 6th. Finally, Panmure Gordon reissued a buy rating and set a GBX 76 ($0.99) price objective on shares of Vernalis plc in a report on Friday, July 8th. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of Buy and an average price target of GBX 73 ($0.95).
Shares of Vernalis plc (LON:VER) opened at 41.489 on Thursday. The stock’s market capitalization is GBX 184.68 million. The firm has a 50-day moving average price of GBX 43.70 and a 200-day moving average price of GBX 45.74. Vernalis plc has a 52-week low of GBX 31.00 and a 52-week high of GBX 79.00.
Vernalis plc Company Profile
Vernalis plc is a commercial-stage pharmaceutical holding company. The Company is engaged in the research, development and commercialization of pharmaceutical products for a range of medical disorders. The Company has two marketed products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine.
Receive News & Stock Ratings for Vernalis plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vernalis plc and related stocks with our FREE daily email newsletter.